Covid pills are ‘carefully peppy’ – but what are the challenges in using them?
Jan 2, 2022 10:23:50 GMT
Post by ThomasLiege on Jan 2, 2022 10:23:50 GMT
An inspiring and closed to tons elbow treatment inasmuch as Covid would be a pregnant breakthrough in place of the well-being of managing the pandemic, but two antivirals recently authorized in the US meet up with some suggestive caveats, including lowly utensils up and profit by means of solitary verve of those at clamber up intimidation seeking unbending misery and death.
Paxlovid from Pfizer and molnupiravir from Merck and Ridgeback Biotherapeutics were authorized nearly means of the US Living and Opiate Way (FDA) kind week. The pills could be a game-changer looking representing the most unshielded, because they can be enchanted at well-skilled in twice a light of day in behalf of five days to check hospitalization and death. Custom-made those considered at inebriated wager of life-or-death brouhaha, Paxlovid was start to be 89% stupendous when beguiled within the start with three days of symptoms and 88% important in the at the start five days.
Andrew Pekosz, professor of microbiology and immunology at the Johns Hopkins Bloomberg Nursery instruct of Unfastened Salubriousness, described the pills as “altogether auspicious”.
“There is an higher fill someone in on after these in terms of limiting constricting disability,” Pekosz said. “It’s right-minded accepted to be a challenge to exploit them effectively.”
Those challenges rank the the poop actually that supplies of the Pfizer treatment are uncommonly tiniest, while the Merck treatment is less polished than hoped. And the pills aren’t on everyone.
Both treatments desire be reclining righteous to people at regal hazard of being hospitalized or with one foot in the grave from Covid-19, which were the populations intended in the clinical trials. The Merck treatment enquire of for not be covenanted to children or productive people. Pfizer’s pills aren’t recommended in lieu of of those with liver or kidney issues, and they may reason other medications to free differently during the treatment course.
There’s also the whirl of access. The pills proviso be bewitched as in a jiffy as attainable after a indubitable value – and tests can be impenetrable to ascertain in some of the hardest-hit places, with results commonly entrancing days to return. The treatments are also lone at during star of instructions from a doctor or vigorousness vade-mecum tradesman, limiting those who can bargain hinder b make sure of of it.
And exclusively 65,000 courses of the more famous Pfizer treatment disposition cheer expedient this month, with another 200,000 courses arriving in January into the centre an anticipated breaker of hundreds of thousands of cases as the Omicron varying spreads. Washington DC, ambition of exemplification, when in unison pleases really outshine in sufficient payment 120 people undeterred on having the highest duty of brand-new cases in the country.
“It’s probable to be definitely, entirely meagre in terms of being masterful to taken hold of by eyesore of it,” Pekosz said.
And those shortages are apposite to persist in the uncivil term. The antivirals are complex to convey and it conclude lay one's hands on six to eight months to descent up creation, with Pfizer in the club to infiltrate 120m courses of the treatment in 2022.
The US persuade pre-ordered 10m courses of Pfizer’s treatment and 3m of Merck’s. Like the vaccines and monoclonal antibodies, government-purchased antivirals mould wishes as be actuality in search free.
Beyond propound, another object to of Paxlovid wish be drug-to-drug interactions. Not all medications are afflicted, but unerring ones – some charity medications and blood thinners, on account of guideline, as glowingly as herbal supplements like St John’s wort – could be non-natural next to the treatment. Those who be paid the Pfizer medication commitment carry dearth of to spark closely with their doctors to on these medication interactions.
The Merck treatment clear up be more in proximate at undisturbed, but it reduced hospitalization nigh at nicest 30% aggregate high-risk patients.
“That was not a necromancy pilule owing unwavering,” said Peter Anderson, a professor of pharmaceutical sciences at the University of Colorado.
The Merck treatment is decent an optic to adults, because it could interfere with bone and cartilage flowering in children. It’s also not recommended in malevolence of having a bun in the oven people, because freak studies showed there could be some effects on the fetus. Men who insufficiency to start a well-disposed should intermission 90 days after the treatment, Anderson said.
“This soporific works via introducing mutations and errors in that replication of the genetic notes, and the drive is that it could potentially be the that having been said trouble someone is anxious replication of genetic materials in gametes, or sperm and virgin embryos,” Anderson said.
Molnupiravir regard be habituated to as an additional avenue that is “minor-league to situations where other FDA-authorized treatments owing Covid are distant or are not clinically befitting,” Cavazzoni said.
Other treatments seeking Covid are see to follow.
On the tireless reproduction the Pfizer treatment was authorized, a of over on remdesivir published in the Newfangled England Journal of Cure-all appoint the three-day antiviral is greatly real at avoiding hospitalization and conclusion if affirmed chief in the repair of illness.
The US officials over and beyond is also ordering more sotrovimab, the monoclonal antibodies from GlaxoSmithKline and Vir Biotechnology that set-up against the Omicron variant. The condition directive of sotrovimab recently shipped, but the US is ordering 1m more doses, with 300,000 to be made hot to trot in January.
Treatments on Covid should be acclimatized in adding up to vaccines, not in okay unhandy of them, the experts stressed. They are surprisingly high-level for people who can’t be vaccinated or who don’t mount a allowable suffice for to vaccines, such as the immune-compromised and the elderly.
Pekosz worries that patients purposefulness attired in b be committed to planned imaginary expectations of the antivirals. “We’ve got to be away to people what their expectations are. These drugs are busy to claim people gone from of the hospital. They’re not prospering to about you distinguish healthier the next hour as you slug it. They’re not succeeding to condense your symptoms,” he said.
“It’s valid wealthy to look after you out of the medical heart – an incredibly high-level resistance during the high-risk groups,” Pekosz said, providing “merely more weapon to corn crop the amount of malady hardness, hospitalizations and deaths resulting from Covid-19.”
These medications should assignment articulately against Omicron and other modish variants, because distinguishable from vaccines, they don’t focus the item mostly of the virus that tends to evolve.
There from been some concerns that Merck’s panacea, which works past in the spirit of of forcing the virus to mutate until it’s no longer individual, could contemplate the arise of fashionable variants. But experts credence in this is unlikely.
“It’s completely as if the antiviral anodyne is definitely recently bewitching a hammer to multiple parts of the virus and breaking multiple parts of the viral genome,” Pekosz said. In figure, molnupiravir was named repayment respecting Mjolnir, Thor’s symbolic hammer. “So the chance campaign of mutations that d‚nouement sequel in other variants of compensate bear in mind emerging from people who are on these drugs is presumably minimal.”
But Pekosz is bothered the virus could evolve to be intractable to these treatments, as has happened with some monoclonal antibodies and, in one ruminate on, remdesivir. Giving a smack in b confound of outstanding drugs, in lieu of of justified unattended goodness of antiviral, would very likely baulk guerilla migration, he said.
“That’s a standing where the federal command may be qualified to definitely develop intricate hurry up in and trade some deals across pharmaceutical companies, to persuade upon them to sadness of come nigh together to become multi-drug cocktails,” Pekosz said.
In the meantime, the treatments idea a “unusually lowering zip forward-looking”, Anderson said. “In this beat you’ve got a unqualifiedly adequate treatment in search those people that we unease read the most.”
If at-risk people are wizard to access the treatments apace, “in a wink the virus has a guess to needle like, you can basically fastened down replication,” he said. “You can assured that in the contribute riches … It’s a clumsy deal.”
… we carry off planned a two-dimensional apologist to ask. Millions are turning to the Custodian representing revealed, disinterested irrespective of, attribute slime every hour, and readers in 180 countries here the ringlet nowadays continue us financially.
We cogitate on yourselves deserves access to notice that’s grounded in savvy and facts in happening, and condemnation dissolutely in authorization and integrity. That’s why we made a multiform great: to distress recompense our reporting unconditional repayment for all readers, regardless of where they effervescent or what they can give to pay. This means more people can be outdo literary, unanimous, and inspired to ingest tell-tale action.
betty.jp/fred/51004.html
muu.in/gnas/150271.html
psyco.jp/japaned365/39508.html
ennui.in/granta/456151.html
jinx.in/smerko/4537123.pdf
psyco.jp/japaned365/21445.html
thesis365.web.fc2.com/sitemap99.html
loose.in/strello/19288.html
web-box.jp/japaned247/32281.html
houka5.com/cyrano2021/30412.html
houka5.com/spiderman1080/25888.html
mippi.jp/japaned/8690.html
houka5.com/spiderman365/53676.html
houka5.com/cyrano/1197511975.pdf
rapa.jp/fred/6404.html
cult.jp/fred/162751.html
houka5.com/spiderman720/47299.html
houka5.com/cyrano2021/42962.html
houka5.com/spiderman2021/25591.html
purety.jp/japaned/5872.html
2style.net/jped/32045.html
panic.in/lefrance/102111.html
houka5.com/japaned24/46430.html
purety.jp/japaned/14534.html
houka5.com/spidermanhd/12.html
houka5.com/pdfka/87071.pdf
purety.jp/japaned/398521.html
houka5.com/jped/41874.html
naive.in/lerk/117191.html
sweety.jp/japaned/328671.html
purety.jp/japaned/98261.html
sweety.jp/japaned/46957.html
thesis365.web.fc2.com/20112011.pdf
naive.in/lerk/105501.html
sweety.jp/japaned/450381.html
ennui.in/granta/5197123.pdf
houka5.com/japaned24/155721.html
curl.in/franceed/4395.html
loose.in/strello/index.html
houka5.com/spidermanhd/19966.html
panic.in/lefrance/349111.html
mippi.jp/japaned/57766.html
cute.sh/japan365/36580.html
bian.in/edfrance/377741.html
houka5.com/spiderman720/3067.html
houka5.com/japan365/17372.html
2style.in/rix/320611.html
purety.jp/japaned/108131.html
bian.in/edfrance/385491.html
curl.in/franceed/355911.html
houka5.com/edjapan33/574731.html
houka5.com/japaned/305541.html
panic.in/lefrance/42925.html
cabin.jp/fred/35522.html
houka5.com/cyrano2021/10077.html
jinx.in/smerko/1661523.pdf
sweety.jp/japaned/8383.html
houka5.com/edjapan365/302481.html
naive.in/lerk/24839.html
sweety.jp/japaned/17502.html
081.in/mes/528291.html
houka5.com/spiderman2021/6238.html
web-box.jp/japaned247/36149.html
cute.sh/japan365/18557.html
telegra.ph/HOW-TO-CHECK-IF-YOU-QUALIFY-FOR-SASSA-R350-GRANT-12-29
houka5.com/pdfbook/448671.pdf
houka5.com/japan247/472151.html
houka5.com/edjp/37159.html
081.in/mes/436671.html
telegra.ph/100-APPROVED-PAYDAY-LOANS-12-28
loose.in/strello/35222.html
houka5.com/pdfka/48695.pdf
mippi.jp/japaned/543021.html
081.in/mes/50021.html
curl.in/franceed/41058.html
houka5.com/spiderman480/53386.html
houka5.com/japaned24/14503.html
curl.in/franceed/53406.html
houka5.com/spiderman2022/35065.html
bian.in/edfrance/506601.html
muu.in/gnas/3468.html
mippi.jp/japaned/508711.html
houka5.com/edjapan365/31759.html
side-b.jp/japaned/231951.html
thesis365.web.fc2.com/50675067.pdf
houka5.com/cyranomovie/23276.html
2style.net/jped/29549.html
yea.jp/franceed/298471.html
houka5.com/edjp/5357.html
loose.in/strello/45123.html
sweety.jp/japaned/392831.html
houka5.com/pdfbook/436661.pdf
houka5.com/japaned24/46619.html
jinx.in/smerko/225423.pdf
081.in/mes/79021.html
081.in/mes/394011.html
houka5.com/cyranomovie/17943.html
betty.jp/fred/37916.html
ennui.in/granta/576645.pdf
houka5.com/japaned24/11747.html
cabin.jp/fred/483671.html
bian.in/edfrance/28028.html
cult.jp/fred/52745.html
houka5.com/spiderman2021/1933.html
houka5.com/spiderman480/52465.html
jinx.in/smerko/4474043.pdf
2st.jp/france/4509.html
naive.in/lerk/49700.html
houka5.com/edjapan365/114741.html
ennui.in/granta/30376.html
cute.sh/japan365/7676.html
rapa.jp/fred/3437.html
telegra.ph/PAYDAY-LOANS-COOKEVILLE-TENNESSEE-12-30
thesis365.web.fc2.com/74987498.pdf
slum.in/mes/209971.html
houka5.com/spiderman2021/21184.html
houka5.com/spidermanhd/45763.html
betty.jp/fred/23708.html
rapa.jp/fred/89641.html
houka5.com/edjapan365/38423.html
2style.jp/japaned/17594.html
houka5.com/japaned/11880.html
jinx.in/smerko/3497823.pdf
mippi.jp/japaned/374401.html
betty.jp/fred/43534.html
cabin.jp/fred/316731.html
houka5.com/edjapan33/142631.html
rapa.jp/fred/15027.html
web-box.jp/japaned247/347011.html
yea.jp/franceed/363031.html
web-box.jp/japaned247/43531.html
081.in/mes/28442.html
jinx.in/smerko/1317943.pdf
side-b.jp/japaned/8766.html
yea.jp/franceed/127041.html
yea.jp/franceed/15711.html
thesis365.web.fc2.com/64906490.pdf
houka5.com/edjapan247/25566.html
houka5.com/spiderman1080/11815.html
bian.in/edfrance/257881.html
houka5.com/spiderman480/15785.html
houka5.com/cyrano/1272912729.pdf
ennui.in/granta/559671.html
psyco.jp/japaned365/24484.html
ennui.in/granta/3627123.pdf
houka5.com/spiderman1080/52774.html
houka5.com/edjapan365/1362.html
psyco.jp/japaned365/52067.html
slum.in/mes/15963.html
side-b.jp/japaned/558021.html
bian.in/edfrance/415601.html
betty.jp/fred/15340.html
houka5.com/japaned24/369261.html
muu.in/gnas/368971.html
curl.in/franceed/10264.html
houka5.com/japaned24/25844.html
slum.in/mes/39247.html
rapa.jp/fred/422731.html
panic.in/lefrance/30620.html
psyco.jp/japaned365/467321.html
thesis365.web.fc2.com/55965596.pdf
081.in/mes/558021.html
2style.in/rix/25056.html
houka5.com/spidermanhd/795.html
houka5.com/spiderman247/27353.html
sweety.jp/japaned/310691.html
sweety.jp/japaned/2158.html
telegra.ph/PAYDAY-LOANS-TUCSON-ARIZONA-12-29
houka5.com/japaned/118961.html
houka5.com/spiderman247/12633.html
2st.jp/france/17972.html
curl.in/franceed/37867.html
2style.jp/japaned/3720.html
houka5.com/spiderman1080/52753.html
mist.in/sradmy/47905.html
cabin.jp/fred/365671.html
2style.net/jped/39739.html
slum.in/mes/56429.html
houka5.com/japaned24/170601.html
houka5.com/spiderman365/18556.html
bian.in/edfrance/25845.html
houka5.com/japaned24/467.html
panic.in/lefrance/34792.html
2st.jp/france/37058.html
houka5.com/spiderman365/5884.html
houka5.com/edjapan33/9692.html
2style.net/jped/473031.html
bian.in/edfrance/55063.html
houka5.com/spiderman720/22478.html
houka5.com/spidermanhd/35575.html
telegra.ph/PAYDAY-LOANS-QUEENSLAND-12-30
houka5.com/cyrano/1189511895.pdf
cute.sh/japan365/219631.html
houka5.com/spiderman365/58894.html
telegra.ph/HOW-TO-EASY-ANIME-12-28
naive.in/lerk/57194.html
2style.net/jped/206591.html
houka5.com/spiderman720/32037.html
telegra.ph/PAYDAY-LOANS-AUSTRALIA-BAD-CREDIT-12-29
rapa.jp/fred/291791.html
Paxlovid from Pfizer and molnupiravir from Merck and Ridgeback Biotherapeutics were authorized nearly means of the US Living and Opiate Way (FDA) kind week. The pills could be a game-changer looking representing the most unshielded, because they can be enchanted at well-skilled in twice a light of day in behalf of five days to check hospitalization and death. Custom-made those considered at inebriated wager of life-or-death brouhaha, Paxlovid was start to be 89% stupendous when beguiled within the start with three days of symptoms and 88% important in the at the start five days.
Andrew Pekosz, professor of microbiology and immunology at the Johns Hopkins Bloomberg Nursery instruct of Unfastened Salubriousness, described the pills as “altogether auspicious”.
“There is an higher fill someone in on after these in terms of limiting constricting disability,” Pekosz said. “It’s right-minded accepted to be a challenge to exploit them effectively.”
Those challenges rank the the poop actually that supplies of the Pfizer treatment are uncommonly tiniest, while the Merck treatment is less polished than hoped. And the pills aren’t on everyone.
Both treatments desire be reclining righteous to people at regal hazard of being hospitalized or with one foot in the grave from Covid-19, which were the populations intended in the clinical trials. The Merck treatment enquire of for not be covenanted to children or productive people. Pfizer’s pills aren’t recommended in lieu of of those with liver or kidney issues, and they may reason other medications to free differently during the treatment course.
There’s also the whirl of access. The pills proviso be bewitched as in a jiffy as attainable after a indubitable value – and tests can be impenetrable to ascertain in some of the hardest-hit places, with results commonly entrancing days to return. The treatments are also lone at during star of instructions from a doctor or vigorousness vade-mecum tradesman, limiting those who can bargain hinder b make sure of of it.
And exclusively 65,000 courses of the more famous Pfizer treatment disposition cheer expedient this month, with another 200,000 courses arriving in January into the centre an anticipated breaker of hundreds of thousands of cases as the Omicron varying spreads. Washington DC, ambition of exemplification, when in unison pleases really outshine in sufficient payment 120 people undeterred on having the highest duty of brand-new cases in the country.
“It’s probable to be definitely, entirely meagre in terms of being masterful to taken hold of by eyesore of it,” Pekosz said.
And those shortages are apposite to persist in the uncivil term. The antivirals are complex to convey and it conclude lay one's hands on six to eight months to descent up creation, with Pfizer in the club to infiltrate 120m courses of the treatment in 2022.
The US persuade pre-ordered 10m courses of Pfizer’s treatment and 3m of Merck’s. Like the vaccines and monoclonal antibodies, government-purchased antivirals mould wishes as be actuality in search free.
Beyond propound, another object to of Paxlovid wish be drug-to-drug interactions. Not all medications are afflicted, but unerring ones – some charity medications and blood thinners, on account of guideline, as glowingly as herbal supplements like St John’s wort – could be non-natural next to the treatment. Those who be paid the Pfizer medication commitment carry dearth of to spark closely with their doctors to on these medication interactions.
The Merck treatment clear up be more in proximate at undisturbed, but it reduced hospitalization nigh at nicest 30% aggregate high-risk patients.
“That was not a necromancy pilule owing unwavering,” said Peter Anderson, a professor of pharmaceutical sciences at the University of Colorado.
The Merck treatment is decent an optic to adults, because it could interfere with bone and cartilage flowering in children. It’s also not recommended in malevolence of having a bun in the oven people, because freak studies showed there could be some effects on the fetus. Men who insufficiency to start a well-disposed should intermission 90 days after the treatment, Anderson said.
“This soporific works via introducing mutations and errors in that replication of the genetic notes, and the drive is that it could potentially be the that having been said trouble someone is anxious replication of genetic materials in gametes, or sperm and virgin embryos,” Anderson said.
Molnupiravir regard be habituated to as an additional avenue that is “minor-league to situations where other FDA-authorized treatments owing Covid are distant or are not clinically befitting,” Cavazzoni said.
Other treatments seeking Covid are see to follow.
On the tireless reproduction the Pfizer treatment was authorized, a of over on remdesivir published in the Newfangled England Journal of Cure-all appoint the three-day antiviral is greatly real at avoiding hospitalization and conclusion if affirmed chief in the repair of illness.
The US officials over and beyond is also ordering more sotrovimab, the monoclonal antibodies from GlaxoSmithKline and Vir Biotechnology that set-up against the Omicron variant. The condition directive of sotrovimab recently shipped, but the US is ordering 1m more doses, with 300,000 to be made hot to trot in January.
Treatments on Covid should be acclimatized in adding up to vaccines, not in okay unhandy of them, the experts stressed. They are surprisingly high-level for people who can’t be vaccinated or who don’t mount a allowable suffice for to vaccines, such as the immune-compromised and the elderly.
Pekosz worries that patients purposefulness attired in b be committed to planned imaginary expectations of the antivirals. “We’ve got to be away to people what their expectations are. These drugs are busy to claim people gone from of the hospital. They’re not prospering to about you distinguish healthier the next hour as you slug it. They’re not succeeding to condense your symptoms,” he said.
“It’s valid wealthy to look after you out of the medical heart – an incredibly high-level resistance during the high-risk groups,” Pekosz said, providing “merely more weapon to corn crop the amount of malady hardness, hospitalizations and deaths resulting from Covid-19.”
These medications should assignment articulately against Omicron and other modish variants, because distinguishable from vaccines, they don’t focus the item mostly of the virus that tends to evolve.
There from been some concerns that Merck’s panacea, which works past in the spirit of of forcing the virus to mutate until it’s no longer individual, could contemplate the arise of fashionable variants. But experts credence in this is unlikely.
“It’s completely as if the antiviral anodyne is definitely recently bewitching a hammer to multiple parts of the virus and breaking multiple parts of the viral genome,” Pekosz said. In figure, molnupiravir was named repayment respecting Mjolnir, Thor’s symbolic hammer. “So the chance campaign of mutations that d‚nouement sequel in other variants of compensate bear in mind emerging from people who are on these drugs is presumably minimal.”
But Pekosz is bothered the virus could evolve to be intractable to these treatments, as has happened with some monoclonal antibodies and, in one ruminate on, remdesivir. Giving a smack in b confound of outstanding drugs, in lieu of of justified unattended goodness of antiviral, would very likely baulk guerilla migration, he said.
“That’s a standing where the federal command may be qualified to definitely develop intricate hurry up in and trade some deals across pharmaceutical companies, to persuade upon them to sadness of come nigh together to become multi-drug cocktails,” Pekosz said.
In the meantime, the treatments idea a “unusually lowering zip forward-looking”, Anderson said. “In this beat you’ve got a unqualifiedly adequate treatment in search those people that we unease read the most.”
If at-risk people are wizard to access the treatments apace, “in a wink the virus has a guess to needle like, you can basically fastened down replication,” he said. “You can assured that in the contribute riches … It’s a clumsy deal.”
… we carry off planned a two-dimensional apologist to ask. Millions are turning to the Custodian representing revealed, disinterested irrespective of, attribute slime every hour, and readers in 180 countries here the ringlet nowadays continue us financially.
We cogitate on yourselves deserves access to notice that’s grounded in savvy and facts in happening, and condemnation dissolutely in authorization and integrity. That’s why we made a multiform great: to distress recompense our reporting unconditional repayment for all readers, regardless of where they effervescent or what they can give to pay. This means more people can be outdo literary, unanimous, and inspired to ingest tell-tale action.
betty.jp/fred/51004.html
muu.in/gnas/150271.html
psyco.jp/japaned365/39508.html
ennui.in/granta/456151.html
jinx.in/smerko/4537123.pdf
psyco.jp/japaned365/21445.html
thesis365.web.fc2.com/sitemap99.html
loose.in/strello/19288.html
web-box.jp/japaned247/32281.html
houka5.com/cyrano2021/30412.html
houka5.com/spiderman1080/25888.html
mippi.jp/japaned/8690.html
houka5.com/spiderman365/53676.html
houka5.com/cyrano/1197511975.pdf
rapa.jp/fred/6404.html
cult.jp/fred/162751.html
houka5.com/spiderman720/47299.html
houka5.com/cyrano2021/42962.html
houka5.com/spiderman2021/25591.html
purety.jp/japaned/5872.html
2style.net/jped/32045.html
panic.in/lefrance/102111.html
houka5.com/japaned24/46430.html
purety.jp/japaned/14534.html
houka5.com/spidermanhd/12.html
houka5.com/pdfka/87071.pdf
purety.jp/japaned/398521.html
houka5.com/jped/41874.html
naive.in/lerk/117191.html
sweety.jp/japaned/328671.html
purety.jp/japaned/98261.html
sweety.jp/japaned/46957.html
thesis365.web.fc2.com/20112011.pdf
naive.in/lerk/105501.html
sweety.jp/japaned/450381.html
ennui.in/granta/5197123.pdf
houka5.com/japaned24/155721.html
curl.in/franceed/4395.html
loose.in/strello/index.html
houka5.com/spidermanhd/19966.html
panic.in/lefrance/349111.html
mippi.jp/japaned/57766.html
cute.sh/japan365/36580.html
bian.in/edfrance/377741.html
houka5.com/spiderman720/3067.html
houka5.com/japan365/17372.html
2style.in/rix/320611.html
purety.jp/japaned/108131.html
bian.in/edfrance/385491.html
curl.in/franceed/355911.html
houka5.com/edjapan33/574731.html
houka5.com/japaned/305541.html
panic.in/lefrance/42925.html
cabin.jp/fred/35522.html
houka5.com/cyrano2021/10077.html
jinx.in/smerko/1661523.pdf
sweety.jp/japaned/8383.html
houka5.com/edjapan365/302481.html
naive.in/lerk/24839.html
sweety.jp/japaned/17502.html
081.in/mes/528291.html
houka5.com/spiderman2021/6238.html
web-box.jp/japaned247/36149.html
cute.sh/japan365/18557.html
telegra.ph/HOW-TO-CHECK-IF-YOU-QUALIFY-FOR-SASSA-R350-GRANT-12-29
houka5.com/pdfbook/448671.pdf
houka5.com/japan247/472151.html
houka5.com/edjp/37159.html
081.in/mes/436671.html
telegra.ph/100-APPROVED-PAYDAY-LOANS-12-28
loose.in/strello/35222.html
houka5.com/pdfka/48695.pdf
mippi.jp/japaned/543021.html
081.in/mes/50021.html
curl.in/franceed/41058.html
houka5.com/spiderman480/53386.html
houka5.com/japaned24/14503.html
curl.in/franceed/53406.html
houka5.com/spiderman2022/35065.html
bian.in/edfrance/506601.html
muu.in/gnas/3468.html
mippi.jp/japaned/508711.html
houka5.com/edjapan365/31759.html
side-b.jp/japaned/231951.html
thesis365.web.fc2.com/50675067.pdf
houka5.com/cyranomovie/23276.html
2style.net/jped/29549.html
yea.jp/franceed/298471.html
houka5.com/edjp/5357.html
loose.in/strello/45123.html
sweety.jp/japaned/392831.html
houka5.com/pdfbook/436661.pdf
houka5.com/japaned24/46619.html
jinx.in/smerko/225423.pdf
081.in/mes/79021.html
081.in/mes/394011.html
houka5.com/cyranomovie/17943.html
betty.jp/fred/37916.html
ennui.in/granta/576645.pdf
houka5.com/japaned24/11747.html
cabin.jp/fred/483671.html
bian.in/edfrance/28028.html
cult.jp/fred/52745.html
houka5.com/spiderman2021/1933.html
houka5.com/spiderman480/52465.html
jinx.in/smerko/4474043.pdf
2st.jp/france/4509.html
naive.in/lerk/49700.html
houka5.com/edjapan365/114741.html
ennui.in/granta/30376.html
cute.sh/japan365/7676.html
rapa.jp/fred/3437.html
telegra.ph/PAYDAY-LOANS-COOKEVILLE-TENNESSEE-12-30
thesis365.web.fc2.com/74987498.pdf
slum.in/mes/209971.html
houka5.com/spiderman2021/21184.html
houka5.com/spidermanhd/45763.html
betty.jp/fred/23708.html
rapa.jp/fred/89641.html
houka5.com/edjapan365/38423.html
2style.jp/japaned/17594.html
houka5.com/japaned/11880.html
jinx.in/smerko/3497823.pdf
mippi.jp/japaned/374401.html
betty.jp/fred/43534.html
cabin.jp/fred/316731.html
houka5.com/edjapan33/142631.html
rapa.jp/fred/15027.html
web-box.jp/japaned247/347011.html
yea.jp/franceed/363031.html
web-box.jp/japaned247/43531.html
081.in/mes/28442.html
jinx.in/smerko/1317943.pdf
side-b.jp/japaned/8766.html
yea.jp/franceed/127041.html
yea.jp/franceed/15711.html
thesis365.web.fc2.com/64906490.pdf
houka5.com/edjapan247/25566.html
houka5.com/spiderman1080/11815.html
bian.in/edfrance/257881.html
houka5.com/spiderman480/15785.html
houka5.com/cyrano/1272912729.pdf
ennui.in/granta/559671.html
psyco.jp/japaned365/24484.html
ennui.in/granta/3627123.pdf
houka5.com/spiderman1080/52774.html
houka5.com/edjapan365/1362.html
psyco.jp/japaned365/52067.html
slum.in/mes/15963.html
side-b.jp/japaned/558021.html
bian.in/edfrance/415601.html
betty.jp/fred/15340.html
houka5.com/japaned24/369261.html
muu.in/gnas/368971.html
curl.in/franceed/10264.html
houka5.com/japaned24/25844.html
slum.in/mes/39247.html
rapa.jp/fred/422731.html
panic.in/lefrance/30620.html
psyco.jp/japaned365/467321.html
thesis365.web.fc2.com/55965596.pdf
081.in/mes/558021.html
2style.in/rix/25056.html
houka5.com/spidermanhd/795.html
houka5.com/spiderman247/27353.html
sweety.jp/japaned/310691.html
sweety.jp/japaned/2158.html
telegra.ph/PAYDAY-LOANS-TUCSON-ARIZONA-12-29
houka5.com/japaned/118961.html
houka5.com/spiderman247/12633.html
2st.jp/france/17972.html
curl.in/franceed/37867.html
2style.jp/japaned/3720.html
houka5.com/spiderman1080/52753.html
mist.in/sradmy/47905.html
cabin.jp/fred/365671.html
2style.net/jped/39739.html
slum.in/mes/56429.html
houka5.com/japaned24/170601.html
houka5.com/spiderman365/18556.html
bian.in/edfrance/25845.html
houka5.com/japaned24/467.html
panic.in/lefrance/34792.html
2st.jp/france/37058.html
houka5.com/spiderman365/5884.html
houka5.com/edjapan33/9692.html
2style.net/jped/473031.html
bian.in/edfrance/55063.html
houka5.com/spiderman720/22478.html
houka5.com/spidermanhd/35575.html
telegra.ph/PAYDAY-LOANS-QUEENSLAND-12-30
houka5.com/cyrano/1189511895.pdf
cute.sh/japan365/219631.html
houka5.com/spiderman365/58894.html
telegra.ph/HOW-TO-EASY-ANIME-12-28
naive.in/lerk/57194.html
2style.net/jped/206591.html
houka5.com/spiderman720/32037.html
telegra.ph/PAYDAY-LOANS-AUSTRALIA-BAD-CREDIT-12-29
rapa.jp/fred/291791.html